The Endotracheal Tube Market is set for significant growth, with global sales reaching US$ 2.2 billion in 2022. According to a newly released analysis report by Future Market Insights, the market is projected to grow at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2033, ultimately reaching an estimated valuation of US$ 4.5 billion by 2033.
This growth is largely attributed to the rising demand for endotracheal tubes in emergency treatment applications, which is expected to be the highest revenue-generating segment in the market, showcasing a robust CAGR of 7.3% during the forecast period. The increasing incidence of respiratory emergencies and the need for effective airway management in critical care settings are key factors driving this upward trend.
As healthcare providers continue to prioritize patient safety and efficient treatment protocols, the endotracheal tube market is poised to expand significantly. Innovations in tube design and materials, aimed at improving patient comfort and clinical outcomes, will also contribute to market growth.
Revenue of Endotracheal Tube Markets from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033
As per the Endotracheal Tube Markets research by Future Market Insights – a market research and competitive intelligence provider, historically, from 2018 to 2022, market value of the Endotracheal Tube Markets increased at around 5.6% CAGR.
An endotracheal tube is a catheter or device that is placed into the trachea of a patient through the mouth or nose. This aids with the administration of anaesthetic gases or air to and from the patient, as well as maintaining an open airway. A large number of endotracheal tubes are constructed of polyvinyl chloride, however tubes with unique requirements are made of silicone rubber, latex rubber, or stainless steel. These tubes come in a variety of shapes and sizes, and are employed according to a patient’s needs and medical condition.
Endotracheal tubes are in increasing demand as the number of surgical procedures increases due to an increase in diseases, such as cardiovascular disease, cancer, and respiratory illness. According to the World Health Organization’s 2019 report, respiratory disorders are the biggest cause of death worldwide, responsible for around 4 million fatalities annually. Owing to this, the market is expected to swell significantly during the forecast period.
Competitive Analysis
The key players in the market include Teleflex Corporation, Medtronic, Medline Industries, Venner Medical, Sonoma Pharmaceutical, Hospiteknik Healthcare, Armstrong Medical, Airway Innovations, and Smith’s Group.
Few of the recent developments of key Endotracheal Tube providers are as follows:
- In April 2020, Hydromer teamed up with N8 Medical to become the official coating and manufacturing partner for the CeraShield Endotracheal Tube, which is used to treat mechanically ventilated COVID-19 patients across Canada.
- In August 2020, Bactiguard’s endotracheal tubes for the prevention of COVID-19 infection received approval from Health Canada under an Interim Order. In critically ill patients, the innovative gadget aids in the reduction of secondary infection risks.
Similarly, recent developments related to companies offering Endotracheal Tube have been tracked by the team at Future Market Insights, which are available in the full report.
Market Segments Covered in Endotracheal Tube Market Analysis
By Product Type:
- Regular Endotracheal Tube
- Reinforced Endotracheal Tube
- Preformed Endotracheal Tube
- Double lumen Endotracheal Tube
By Route Type:
- Orotracheal
- Nasotracheal
By Application:
- Emergency Treatment
- Therapy
- Other Applications
By End-use:
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Other End-uses
By Region:
- North America
- USA
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Belgium
- Switzerland
- Russia
- Sweden
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Malaysia
- Singapore
- Philippines
- Thailand
- New Zealand
- South Korea
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
